ERBB2 gene as a potential therapeutic target in small bowel adenocarcinoma.
Anais Laforest
No relevant relationships to disclose
Thomas Aparicio
No relevant relationships to disclose
Aziz Zaanan
No relevant relationships to disclose
Fabio pittella Silva
No relevant relationships to disclose
Audrey Didelot
No relevant relationships to disclose
Aurelien Desbeaux
No relevant relationships to disclose
Delphine Le Corre
No relevant relationships to disclose
Leonor Benhaim
No relevant relationships to disclose
Karine Pallier
No relevant relationships to disclose
Daniela Ellen Aust
No relevant relationships to disclose
Steffen Pistorius
No relevant relationships to disclose
Helene Blons
No relevant relationships to disclose
Magali Svrcek
No relevant relationships to disclose
Pierre Laurent-Puig
Honoraria - Amgen; Merck Serono